Global Business Trends

  The BRICS transcranial stimulation devices market is experiencing strong growth as hospitals, psychiatric centers, neurological clinics, and rehabilitation facilities increasingly invest in advanced non-invasive brain stimulation technologies. Rising awareness of mental health, increasing diagnosis of neurological disorders, expanding access to specialized healthcare services, and growing adoption of evidence-based neuromodulation therapies are contributing significantly to market expansion across the region. According to Business Market Insights, the BRICS Transcranial Stimulation Devices Market is expected to witness robust growth during the forecast period, reaching US$ 316.8 million by 2033 from US$ 123.9 million in 2025. The market is estimated to record a CAGR of 12.5% from 2026 to 2033. Transcranial stimulation devices, including Transcranial Magnetic Stimulation (TMS) and Transcranial Direct Current Stimulation (tDCS) systems, are used for non-invasive neuromodulation....

  The South and Central America transcranial stimulation devices industry is undergoing continuous innovation, supported by increasing investments in neurological healthcare, rehabilitation services, and advanced medical technologies. Manufacturers are developing next-generation transcranial stimulation systems designed to provide enhanced brain stimulation accuracy, improved clinical efficiency, personalized treatment options, and greater patient safety while addressing the evolving needs of healthcare providers across the region. According to Business Market Insights, the South and Central America Transcranial Stimulation Devices Market is projected to increase from US$ 33.5 million in 2025 to US$ 64.1 million by 2033. This growth reflects a projected CAGR of 8.5% during the 2026–2033 forecast period. Transcranial stimulation devices, including transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), offer non-invasive methods to modulate bra...